Skip to main content
Top

Current Treatment Options in Oncology

Issue 5/2015

Content (6 Articles)

Gynecologic Cancers (RJ Morgan, Section Editor)

Dose-Dense Approaches to Ovarian Cancer Treatment

Noriyuki Katsumata

Sarcoma (SH Okuno, Section Editor)

Role of Genetic and Molecular Profiling in Sarcomas

Scott M. Norberg, Sujana Movva

Sarcoma (SH Okuno, Section Editor)

Soft Tissue Sarcoma and Radiation Therapy Advances, Impact on Toxicity

Nancy El-Bared, Philip Wong, Dian Wang

Upper Gastrointestinal Cancers (L Rajdev, Section Editor)

Immunotherapy in Upper GI Malignancies

Adrian Murphy, Ronan J. Kelly

Breast Cancer (P Neven, Section Editor)

Indications for Prognostic Gene Expression Profiling in Early Breast Cancer

Erin F. Cobain, Daniel F. Hayes

Breast Cancer (P Neven, Section Editor)

Obesity and Breast Cancer: Not Only a Risk Factor of the Disease

Doris S. M. Chan, Teresa Norat

Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine